Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy
Clinical trial NCT05451719 · UNKNOWN
Trial details
- NCT number
- NCT05451719
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2024-07-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.